Psycheceutical Bioscience Inc
OTC:BWVI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Psycheceutical Bioscience Inc
OTC:BWVI
|
US |
|
Cheng Uei Precision Industry Co Ltd
TWSE:2392
|
TW |
|
C
|
Calibre Mining Corp
OTC:CXBMF
|
CA |
|
Ezconn Corp
TWSE:6442
|
TW |
Cash Flow Statement
Cash Flow Statement
Psycheceutical Bioscience Inc
| Dec-2006 | Mar-2007 | Jun-2007 | Sep-2007 | Dec-2007 | Mar-2008 | Jun-2008 | Sep-2008 | Dec-2008 | Mar-2009 | Jun-2009 | Sep-2009 | Dec-2009 | Mar-2010 | Jun-2010 | Sep-2010 | Dec-2010 | Mar-2011 | Jun-2011 | Sep-2011 | Dec-2011 | Mar-2012 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||||
| Net Income |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
0
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Operating Activities |
0
N/A
|
0
+25%
|
0
N/A
|
(0)
N/A
|
0
N/A
|
(1)
N/A
|
(0)
+19%
|
(1)
-50%
|
(1)
-15%
|
(0)
+64%
|
(0)
-52%
|
(0)
+57%
|
0
N/A
|
0
+101%
|
0
+129%
|
0
+18%
|
0
-46%
|
0
+3%
|
(0)
N/A
|
(0)
-874%
|
0
N/A
|
0
+2 715%
|
|
| Investing Cash Flow | |||||||||||||||||||||||
| Capital Expenditures |
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
|
| Other Items |
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
(0)
N/A
|
(0)
-20%
|
(0)
-60%
|
(0)
-13%
|
(0)
+42%
|
(0)
-14%
|
(0)
+50%
|
(0)
-17%
|
(0)
+28%
|
0
N/A
|
0
-10%
|
0
-11%
|
0
+47%
|
0
-100%
|
0
+2 400%
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Financing Cash Flow | |||||||||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
|
| Other |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
(0)
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
1
|
0
|
|
| Cash from Financing Activities |
(0)
N/A
|
(0)
-25%
|
(0)
N/A
|
0
N/A
|
1
N/A
|
1
-20%
|
1
+1%
|
1
+2%
|
(0)
N/A
|
(0)
+67%
|
(0)
+40%
|
(0)
-67%
|
0
N/A
|
(0)
N/A
|
(0)
-200%
|
0
N/A
|
(1)
N/A
|
(0)
+58%
|
(0)
-3%
|
0
N/A
|
1
+334%
|
0
-27%
|
|
| Change in Cash | |||||||||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
|
| Net Change in Cash |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
+4 480%
|
1
-62%
|
1
+15%
|
0
-38%
|
(1)
N/A
|
(0)
+57%
|
(1)
-14%
|
(0)
+36%
|
0
N/A
|
0
+95%
|
0
+73%
|
1
+22%
|
(0)
N/A
|
0
N/A
|
(0)
N/A
|
0
N/A
|
1
+1 424%
|
1
0%
|
|
| Free Cash Flow | |||||||||||||||||||||||
| Free Cash Flow |
0
N/A
|
0
+25%
|
0
N/A
|
(0)
N/A
|
0
N/A
|
(1)
N/A
|
(0)
+19%
|
(1)
-49%
|
(1)
-21%
|
(0)
+56%
|
(1)
-41%
|
(0)
+48%
|
0
N/A
|
0
+313%
|
0
+157%
|
0
+19%
|
0
-47%
|
0
+11%
|
(0)
N/A
|
(0)
-874%
|
0
N/A
|
0
+2 715%
|
|